Annual Total Liabilities
$140.62 M
-$330.50 M-70.15%
December 31, 2024
Summary
- As of March 2, 2025, LAB annual total liabilities is $140.62 million, with the most recent change of -$330.50 million (-70.15%) on December 31, 2024.
- During the last 3 years, LAB annual total liabilities has fallen by -$40.00 million (-22.14%).
- LAB annual total liabilities is now -70.19% below its all-time high of $471.78 million, reached on December 31, 2022.
Performance
LAB Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$140.62 M
-$51.58 M-26.84%
December 31, 2024
Summary
- As of March 2, 2025, LAB quarterly total liabilities is $140.62 million, with the most recent change of -$51.58 million (-26.84%) on December 31, 2024.
- Over the past year, LAB quarterly total liabilities has dropped by -$330.50 million (-70.15%).
- LAB quarterly total liabilities is now -70.62% below its all-time high of $478.58 million, reached on June 30, 2022.
Performance
LAB Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
LAB Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -70.2% | -70.2% |
| 3 y3 years | -22.1% | -70.0% |
| 5 y5 years | +26.5% | -70.0% |
LAB Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -70.2% | at low | -70.6% | at low |
| 5 y | 5-year | -70.2% | +26.5% | -70.6% | +26.5% |
| alltime | all time | -70.2% | +975.5% | -70.6% | +975.5% |
Standard BioTools Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $140.62 M(-70.2%) | $140.62 M(-26.8%) |
| Sep 2024 | - | $192.21 M(-3.2%) |
| Jun 2024 | - | $198.47 M(-0.9%) |
| Mar 2024 | - | $200.35 M(-57.5%) |
| Dec 2023 | $471.12 M(-0.1%) | $471.12 M(+0.0%) |
| Sep 2023 | - | $471.00 M(+0.4%) |
| Jun 2023 | - | $469.21 M(+0.1%) |
| Mar 2023 | - | $468.81 M(-0.6%) |
| Dec 2022 | $471.78 M(+161.2%) | $471.78 M(-1.2%) |
| Sep 2022 | - | $477.66 M(-0.2%) |
| Jun 2022 | - | $478.58 M(+91.6%) |
| Mar 2022 | - | $249.82 M(+38.3%) |
| Dec 2021 | $180.62 M(-2.7%) | $180.62 M(-1.2%) |
| Sep 2021 | - | $182.85 M(+1.7%) |
| Jun 2021 | - | $179.87 M(-1.3%) |
| Mar 2021 | - | $182.26 M(-1.9%) |
| Dec 2020 | $185.71 M(+67.0%) | - |
| Dec 2020 | - | $185.71 M(+8.6%) |
| Sep 2020 | - | $171.00 M(+14.3%) |
| Jun 2020 | - | $149.63 M(+0.6%) |
| Mar 2020 | - | $148.72 M(+33.7%) |
| Dec 2019 | $111.20 M(-52.0%) | - |
| Dec 2019 | - | $111.20 M(+4.1%) |
| Sep 2019 | - | $106.79 M(-3.9%) |
| Jun 2019 | - | $111.15 M(+1.8%) |
| Mar 2019 | - | $109.20 M(-52.8%) |
| Dec 2018 | $231.53 M(-9.7%) | $231.53 M(+0.7%) |
| Sep 2018 | - | $229.88 M(+2.5%) |
| Jun 2018 | - | $224.27 M(+1.4%) |
| Mar 2018 | - | $221.13 M(-13.8%) |
| Dec 2017 | $256.42 M | $256.42 M(+1.4%) |
| Sep 2017 | - | $252.93 M(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $254.77 M(+0.3%) |
| Mar 2017 | - | $253.97 M(+0.3%) |
| Dec 2016 | $253.16 M(-0.8%) | $253.16 M(+0.3%) |
| Sep 2016 | - | $252.45 M(-2.1%) |
| Jun 2016 | - | $257.77 M(+0.9%) |
| Mar 2016 | - | $255.46 M(+0.1%) |
| Dec 2015 | $255.15 M(-0.8%) | $255.15 M(+0.3%) |
| Sep 2015 | - | $254.36 M(-0.6%) |
| Jun 2015 | - | $255.91 M(+1.3%) |
| Mar 2015 | - | $252.58 M(-1.8%) |
| Dec 2014 | $257.14 M(+1154.3%) | $257.14 M(+0.5%) |
| Sep 2014 | - | $255.84 M(-0.0%) |
| Jun 2014 | - | $255.92 M(-0.5%) |
| Mar 2014 | - | $257.29 M(+1155.0%) |
| Dec 2013 | $20.50 M(+56.8%) | $20.50 M(+19.0%) |
| Sep 2013 | - | $17.23 M(+26.9%) |
| Jun 2013 | - | $13.58 M(+3.6%) |
| Mar 2013 | - | $13.11 M(+0.3%) |
| Dec 2012 | $13.07 M(-41.7%) | $13.07 M(-9.4%) |
| Sep 2012 | - | $14.44 M(-9.8%) |
| Jun 2012 | - | $16.01 M(-14.7%) |
| Mar 2012 | - | $18.77 M(-16.3%) |
| Dec 2011 | $22.43 M(-89.5%) | $22.43 M(-4.4%) |
| Sep 2011 | - | $23.45 M(+0.4%) |
| Jun 2011 | - | $23.35 M(-10.0%) |
| Mar 2011 | - | $25.95 M(-87.9%) |
| Dec 2010 | $213.97 M(+4.0%) | $213.97 M(+809.0%) |
| Sep 2010 | - | $23.54 M(-88.6%) |
| Dec 2009 | $205.77 M(+7.9%) | $205.77 M(+7.9%) |
| Dec 2008 | $190.69 M(+3.0%) | $190.69 M(-2.0%) |
| Jun 2008 | - | $194.59 M(+5.1%) |
| Dec 2007 | $185.11 M(+29.7%) | $185.11 M |
| Dec 2006 | $142.66 M | - |
FAQ
- What is Standard BioTools annual total liabilities?
- What is the all time high annual total liabilities for Standard BioTools?
- What is Standard BioTools annual total liabilities year-on-year change?
- What is Standard BioTools quarterly total liabilities?
- What is the all time high quarterly total liabilities for Standard BioTools?
- What is Standard BioTools quarterly total liabilities year-on-year change?
What is Standard BioTools annual total liabilities?
The current annual total liabilities of LAB is $140.62 M
What is the all time high annual total liabilities for Standard BioTools?
Standard BioTools all-time high annual total liabilities is $471.78 M
What is Standard BioTools annual total liabilities year-on-year change?
Over the past year, LAB annual total liabilities has changed by -$330.50 M (-70.15%)
What is Standard BioTools quarterly total liabilities?
The current quarterly total liabilities of LAB is $140.62 M
What is the all time high quarterly total liabilities for Standard BioTools?
Standard BioTools all-time high quarterly total liabilities is $478.58 M
What is Standard BioTools quarterly total liabilities year-on-year change?
Over the past year, LAB quarterly total liabilities has changed by -$330.50 M (-70.15%)